An analysis of Tesamorelin’s GHRHR class B GPCR binding mechanism, DPP-IV resistance from its trans-3-hexenoyl modification, and the inferred downstream lipolysis cascade in visceral adipose tissue research.

Sermorelin is a synthetic GHRH(1-29) analog studied for its two-step GHRHR class B GPCR binding mechanism and Gs-cAMP-PKA-CREB-Pit-1 cascade activation in pituitary somatotrophs.

A research-context examination of MK-677’s non-peptide GHSR-1a agonism, including Gq/11-PLC-PKC-IP3 calcium signaling, tonic GH secretion pattern characteristics, and mechanistic distinctions from peptide-based GH secretagogues in preclinical research.

A preclinical research overview of GHRP-2 focusing on Hepatic GH receptor (GHR) downstream signaling following GHRP-2-induced GH release: JAK2-STAT5b phos…

An analysis of how GHRP-2 engages GHSR-1a to functionally antagonize somatostatinergic inhibitory tone from periventricular nucleus neurons, with examination of GH pulsatility dynamics, SSTR2 and SSTR5 context, and the indirect mechanism underlying somatostatin counter-regulation in rodent neuroendocrine models.

An examination of Hexarelin’s CD36 scavenger receptor co-agonism in cardiac research models, distinguishing ERK1/2-PI3K-Akt RISK pathway activation from GHSR-1a-mediated GH secretion mechanisms.

A research-context analysis of GHRP-2’s pharmacology at the GHS-R1a receptor, including constitutive Gq/11 activity, GHS-R1a/1b heterodimer attenuation dynamics, clathrin-mediated internalization via beta-arrestin and Rab GTPases, and the PLC/IP3/calcium cascade in pituitary cell culture models.

A research-context synthesis of current preclinical findings around Tesamorelin and related biological systems, with explicit attention to study limitations.

← Back to The GH Pulse Section 1: Compound Overview (Research Context Only) Hexarelin is a synthetic hexapeptide with the amino acid sequence His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH2. The D-amino acid substitutions, mirror-image versions of standard amino acids found in natural proteins, give Hexarelin greater resistance to enzymatic degradation compared to many endogenous peptides. In preclinical and in vitro […]

What Current Research Suggests About Sermorelin in GHRH Receptor Agonism

← Back to The GH Pulse Sermorelin occupies a specific and technically defined position in peptide research. It is a synthetic 29-amino acid fragment corresponding to the N-terminal sequence of endogenous growth hormone-releasing hormone, commonly designated GHRH(1-44). That truncation is the central fact around which most mechanistic questions about this compound are organized. Researchers working […]